Drugs & Targets Keytruda + chemo gets EC approval for locally recurrent unresectable or metastatic triple-negative breast cancer October 22, 2021Vol.47 No.39
Drugs & Targets Opdivo + chemo gets EC approval for metastatic gastric cancer, GEJ cancer, or EAC October 22, 2021Vol.47 No.39
Drugs & Targets Point32Health, Takeda enter risk-sharing agreement for Alunbrig in ALK+NSCLC October 22, 2021Vol.47 No.39
Drugs & Targets FDA approval makes Tecentriq the first adjuvant treatment for NSCLC October 15, 2021Vol.47 No.38
Drugs & Targets Verzenio with endocrine therapy gets FDA approval for early breast cancer October 15, 2021Vol.47 No.38
Drugs & Targets Keytruda combination gets FDA approval for first-line cervical cancer treatment October 15, 2021Vol.47 No.38
Drugs & Targets FDA authorizes first e-cigarette products, alarming cancer prevention advocates October 15, 2021Vol.47 No.38
Drugs & Targets Qinlock approved in Switzerland for fourth-line gastrointestinal stromal tumor October 15, 2021Vol.47 No.38
Drugs & Targets Mayo Clinic collaborates with Personalis to expand cancer genomic testing October 15, 2021Vol.47 No.38
